Total Debt of Approx. 17.6 Billion Yen, the Largest in 10 Years; Bankrupt Companies in Kumamoto Prefecture in 2025 Include “Kumamoto Kanko Kaihatsu,” “AT Seisan Kaisha,” and “Medical Corporation Mikokai” – TBS NEWS DIG

The news that "Medical Corporation Mikokai" is listed among bankrupt companies in Kumamoto Prefecture in 2025, with total liabilities reaching approximately 17.6 billion yen, the largest in the past 10 years, further highlights the harsh management environment in the medical industry.

Deterioration of medical institution management is accelerated by a combination of factors such as stagnant medical fee increases, rising expenses due to inflation, and increasing labor costs for healthcare professionals. Particularly in medical fields where capital investment burdens are high, these factors can lead to a rapid worsening of financial conditions. The situation where a medical corporation of "Mikokai's" scale faces substantial debt serves as a warning to the entire industry.

This news strongly suggests the importance of early management improvement and succession planning in the context of medical M&A and business succession. It is crucial to identify early warning signs of deteriorating management and consult with experts before liabilities grow and the company becomes insolvent. Early intervention allows for securing a sale price, negotiating the release of personal guarantees, and, most importantly, enabling a smooth business succession that minimizes the impact on regional healthcare continuity, staff, and patients.

For medical institution executives and those facing succession issues, the case of "Mikokai" should serve as an opportunity to recognize the value of consulting with trusted M&A advisors or consultants before problems become apparent. Succession is not merely a "sale"; it can be a means of management improvement and a fresh start to protect regional healthcare, maintain staff employment, and provide reassurance to patients.